Table 4.
JIA medication exposure group | Referent Group | Unadjusted Relative Hazard (95% CI) | Adjusted* Relative Hazard (95% CI) |
---|---|---|---|
JIA: no current MTX, no current TNF inhibitor | ADHD | 3.3 (2.6–4.1) | 2.0 (1.5–2.5) |
JIA: current MTX, no current TNF inhibitor | JIA: no current MTX, no current TNF inhibitor | 1.3 (1.0–1.7) | 1.2 (0.9–1.7) |
JIA: current TNF inhibitor, irrespective of MTX | JIA: current MTX, no current TNF inhibitor | 1.3 (0.9–1.9) | 1.2 (0.8–1.8) |
JIA = juvenile idiopathic arthritis; ADHD = attention-deficit hyperactivity disorder; MTX = methotrexate or leflunomide; TNF inhibitor = etanercept, infliximab, or adalimumab; GC = glucocorticoids
Adjusted for patient age, sex, race, hospitalized bacterial infection during baseline, outpatient bacterial infection during baseline, asthma, diabetes mellitus, GC dose on index date (none, low (< 10 mg prednisone equivalents per day), or high (≥ 10 mg prednisone equivalents per day)).